CRISPR-Based Test Enables Fast and Accurate Detection of SARS-CoV-2 VariantsAugust 24, 2022
Researchers from Princeton University and the Broad Institute have created an easy-to-use diagnostic COVID-19 test that is more sensitive than the commonly used at-home antigen tests and allows for the rapid and specific detection of SARS-CoV-2 variants in point-of-care settings.
The improved COVID-19 test detects the virus using a different mechanism than the more familiar clinic-based PCR or at-home antigen tests. Instead, the test detects viruses using CRISPR gene editing technology. CRISPR originated from a bacteria-based system to detect and defend against viral infections and is uniquely suited to rapidly identifying specific genetic sequences.
Cameron Myhrvold, an assistant professor in the Department of Molecular Biology at Princeton, previously worked with Broad Institute member and Harvard University professor Pardis Sabeti to develop a CRISPR-based test that could be tailored to diagnose specific viral infections. Myhrvold's team called their test SHINE to detect SARS-CoV-2 with remarkable sensitivity. The improved test is called "SHINEv.2" and was able to quickly discern between infections from the Alpha, Beta, Delta, or Omicron SARS-CoV-2 variants in patient samples. The team says the test can be rapidly modified to pick up on any other variants that may arise.
For more details, read the article on the Princeton University website.
You might also like:
- UC San Diego Researchers Develop CRISPR-based Rapid Diagnostic Tool for SARS-CoV-2
- MIT and Harvard University Engineers Design Tabletop Device that Detects SARS-CoV-2 from Saliva in One Hour
- CRISPR Technique 90% Effective in Reducing SARS-CoV-2 Coronavirus
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
Gene Editing Supplement (August 24, 2022)
Research and Tools
- Enhanced Green Fluorescent Marker Effective in Transforming Grapes Using CRISPR
- UC San Diego Researchers Use CRISPR to Target Global Crop Pest
- CRISPR Method Successfully Developed for Medicinal Fungus
- CRISPR-Based Test Enables Fast and Accurate Detection of SARS-CoV-2 Variants
- FDA Approves CRISPR-based Therapeutic for Trial
Trends and Impact
- CRISPR Market Size to Reach US$3.73B by 2032
Read the latest:
- Biotech Updates (May 24, 2023)
- Gene Editing Supplement (May 24, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: